AgriTech

A multidisciplinary sector addressing the challenges of improving global agricultural productivity.

Agriculture is at the heart of human civilization, but traditional methods alone can’t meet the demands of our growing population and changing climate. Enter Agritech – the fusion of agriculture and technology. Agritech is transforming farming practices, enhancing productivity, and ensuring sustainability for future generations. Improvements in efficiency and sustainability in agriculture continue to drive ingenious solutions that harness various cutting-edge technologies, such as genomics and gene editing, robotics, microbiome, big data, algorithms and AI.

As such, inventions in this sector increasingly involve crossover technologies. Our Agritech Team includes highly experienced attorneys across life sciences, chemistry, and engineering, who are familiar with pooling expertise and working in multidisciplinary teams to service your IP needs. Our Agritech Team works closely with our unique specialists in microbiome and bioinformatics, and can further assist with seeking protection for plant variety rights alongside patents.

HGF’s attorneys are already working at the forefront of agricultural innovation. We deal with inventions in accelerated plant breeding procedures, algal culturing, genetically engineered or modified crops, actives and formulations for plant protection products such as herbicides and pesticides, soil monitoring and preparations, growing and farming apparatus, surveillance and diagnostics, precision and digital agriculture, genetically engineered or modified animals, improved husbandry methods, microbiome and carbon neutral systems.

We believe in building lasting partnerships with our clients. Our team of experts is always available to provide integrated IP support and guidance, helping you make the most of your agritech inventions.

For more information on how our Agritech team can help you with your IP, please contact us to speak with one of our attorneys.

Latest updates

When AI Designs the Ingredient: Who Controls the Data, the Model and the Discovery?

AI-enabled discovery has drawn significant attention in pharmaceutical R&D, but its impact is extending into other industries, across ingredients, food, flavour, fragrance and industrial biotechnology. As AI models advance, the …

Read article

Protecting the AI Drug Discovery Ecosystem: Building an IP Stack Around Targets, Molecules and Medicines

Despite the considerable costs and effort in target identification, candidate generation, selection and advancement to clinical trials, 90% of candidates that enter clinical trials during drug discovery fail (Sun D, …

Read article

Agritech Thymes: UK-EU SPS agreement – what does it mean for plant breeders?

Since Brexit, the UK agrifood sector has faced difficulties, largely due to the requirement for additional certifications and controls, such as phytosanitary certificates and border checks. This has had a …

Read article

How Low Can You Go? T 0137/24, Percentage Sequence Identity Claims and Divergent EPO and USPTO Approaches

Key takeaways Increasing percentage sequence identity thresholds may be selected from a disclosed convergent list without adding matter, provided the amendment does not create a new technical combination; Broader percentage …

Read article

Designing the Exit: IP Strategy for Venture-Backed Biotech

In venture-built biotech, value is not created at the point of exit, but is designed into the asset from the very beginning. The earliest decisions made around a scientific discovery …

Read article

Five Questions VCs Should Ask About IP Before They Invest

Intellectual property diligence too often starts with the wrong question: how many patents does the company have? For venture investors, that is rarely the most revealing answer. The real issue …

Read article
HGF logo

HGF in Conversation: Andrew Tindall on the IP Landscape of Personalised Medicine

How is the convergence of genomics, AI, diagnostics and gene therapies reshaping healthcare, and what does this mean for intellectual property? Andrew Tindall, Patent Director at HGF, recently joined Parola …

Read article
HGF logo

PRESS RELEASE - HGF strengthens Life Sciences practice with appointment of Dr Russell Thom

HGF has strengthened its European Life Sciences practice with the appointment of Dr Russell Thom, who joins the firm as a Partner 1st August 2026. Russell brings more than 25 …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our agritech specialists.